Reumatoloxía e Enfermidades Inmuno-mediadas ‘IRIDIS’
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (32)
2024
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
-
Tumor-induced osteomalacia: A systematic literature review
Bone Reports, Vol. 21
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
-
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12
Reumatologia Clinica
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study
Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096
-
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Reumatologia Clinica, Vol. 18, Núm. 6, pp. 317-330
2021
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336
-
Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice
Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558
2020
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36